CI
AMRI

Cowen Inc’s Albany Molecular Research Inc AMRI Stock Holding History

Cowen Inc’s Portfolio AMRI Stock Details AMRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-800
Closed -$17K – 394
2017
Q2 		$17K Buy
+800
New +$14.5K ﹤0.01% 300

Other funds holding AMRI

AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Cowen Inc's AMRI Position: Q3 2017 in Review

Cowen Inc sold out of Albany Molecular Research Inc (AMRI) in Q3 2017, closing a stake of 35,000 shares — an estimated $760K sold.

Cowen Inc first reported a position in AMRI in Q1 2015 and held it in 3 quarters. The position peaked at $760K in Q2 2017. 2 funds tracked by Wall St. Rank hold AMRI as of Q3 2017.

  • Cowen Inc reported no remaining Albany Molecular Research Inc position as of Q3 2017 after selling out during the quarter.
  • Cowen Inc sold 35,000 Albany Molecular Research Inc shares in Q3 2017, an estimated $760K.
  • Cowen Inc first reported a position in Albany Molecular Research Inc in Q1 2015 and held it in 3 quarters.
  • Cowen Inc's Albany Molecular Research Inc position peaked at $760K in Q2 2017.
  • 2 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q3 2017.

Based on Cowen Inc's 13F filing for Q3 2017, filed 14 Nov 2017.